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Upper extremity access for FEVAR was used in 98 (66.2%) patients. The
median number of vessels fenestrated was 3 (interquartile range, 2-4),
with a total of 457 vessels stented. Twelve were percutaneous (12.2%)
and 86 (87.8%) were open. All patients that required a sheath size >7F
underwent high brachial open access, with the exception of 1 patient who
underwent percutaneous axillary access with a 12F sheath. The median
sheath size was 12F (interquartile range, 10-12), which was advanced into
the descending thoracic aorta allowing multiple wire and catheter
exchanges.
Results: One (1/98; 1.0%) hemorrhagic stroke in the upper
extremity access group and one (1/54; 1.9%) ischemic stroke in the
femoral-only access group occurred (P ¼ .67). The stroke in the upper
extremity access group occurred 5 days after FEVAR and was related to
uncontrolled hypertension, whereas the stroke in the femoral group
occurred on postoperative day 3. Neither patient had signs or symptoms
of a stroke immediately after FEVAR. The right upper extremity was
accessed six times without a stroke (0/6; 0%), compared with the left being
accessed 92 times with one stroke (1/92; 1.1%) (P ¼ .8). Four (4.1%)
patients had complications related to upper extremity access; one (1.0%)
required exploration for an expanding hematoma after manual compression
for a 7F sheath, one (1.0%) required exploration for hematoma and neuro-
logic symptoms after open access for a 12F sheath; and two (2.0%) patients
with small hematomas did not require intervention. Two (2/12; 16.7%) of
these complications were in the percutaneous access group, which were
signiﬁcantly more frequent than in the open group (2/86; 2.3%) (P ¼ .02).
Conclusions: Upper extremity access appears to be a safe and feasible
approach for patients undergoing FEVAR. Open exposure in the upper
extremity may be safer than percutaneous access during FEVAR. Unlike
chimney and snorkel grafts, upper extremity access during FEVAR is not
associated with an increased risk of stroke, despite the need for multiple
visceral vessel stenting.
Bedside Vena Cava Filter Placement Using Intravascular Ultrasound:
A 5-Year Experience in Critically Ill Patients
Roan J. Glocker, Oluwafunmi Awonuga, Zdenek Novak, Benjamin Pearce,
Thomas Matthews, Mark Patterson, William Jordan Jr, Marc Passman.
University of Alabama at Birmingham, Birmingham, Ala
Objectives: Initial experience with a prospectively implemented algo-
rithm for bedside vena cava ﬁlter placement with intravascular ultrasound
(IVUS) has previously been shown to be a safe and effective technique espe-
cially for critically ill patients. The purpose of this study is to evaluate the
effectiveness of IVUS guided ﬁlter placement in critically ill patients with
experience now extending out 5 years from implementation.
Methods: All patients undergoing bedside IVUS-guided inferior vena
cava (IVC) ﬁlter placement from 2008-2012 were identiﬁed. Records were
reviewed based on IVC ﬁlter reporting standards. Outcome data including
technical success, complications, and mortality were analyzed at 30 days.
Results: Three-hundred ninety-eight patients underwent bedside IVC
ﬁlter placement with IVUS. Overall technical success was 97.9% with
inability to place ﬁlter due to poor visualization (2), and malpositioned ﬁlters
either above or below the intended infrarenal position (11). An optional
ﬁlter (Gunter Tulip or Celect) was used in 374 (93.9%) and a permanent
ﬁlter (Greenﬁeld) in 24 (6.1%). Single puncture technique was performed
in 388 (97.4%) with additional dual access required in 10 (2.6%). Periproce-
dural complications were rare (3.0%) and included malpositioning requiring
retrieval and repositioning or additional ﬁlter (3), ﬁlter tilt$20 (4), arterio-
venous ﬁstula (2), insertion site thrombosis (2), and hematoma (1).
Comparison of the ﬁrst and last 100 procedures in the sample population
showed that there was a trend toward improved complication rates in the
later experience (7.0% vs 2.0%; P ¼ .08, respectively). There were no deaths
related to pulmonary embolism or ﬁlter related problems.
Conclusions: Based on a 5-year experience with bedside IVC ﬁlter
placement in critically ill patients, IVUS-guided ﬁlter techniques continue
to be a safe and effective option in this high risk population with a time-
dependent improvement in outcome measures.
C-Reactive Protein and Brain Natriuretic Peptide as Predictors of
Adverse Events Following Lower Extremity Endovascular
Revascularization
Patrick A. Stone, Haley Schlarb, Stephanie Thompson. West Virginia
University, Charleston, WVa
Objectives: High sensitivity-C-reactive protein (CRP) and brain
natriuretic peptide (BNP) have been shown to be independent predictors
of adverse cardiovascular outcomes and potentially increased risk of
secondary interventions or limb loss in patients with peripheral arterialdisease (PAD). To assist clinicians in predicting postprocedure mortality
and morbidity and decision-making regarding treatment approaches, we
retrospectively examined patients with preprocedure CRP and BNP levels
who underwent elective angioplasty and/or stent placement for lower
extremity PAD.
Methods: The study period included patients treated between 2007
and 2012. Minimal required follow-up was at least one postoperative ankle
brachial index or duplex imaging of the treated limb. Events of interest
included clinical limb failure (loss of patency, target vessel revascularization,
decrease in ankle brachial index >0.15 or limb amputation) by 1 year and
MACE (stroke, myocardial infarction or death) by 2 years. Elevated/
abnormal values for our biomarkers of interest were established by the upper
limited of our institution’s clinical laboratory reference range hs-CRP
(<0.80 mg/dL), BNP (<100 pg/mL).
Results: A total of 159 limbs in 118 patients were included in analysis
(42% male, mean age 64 6 11 years). All limbs were symptomatic (Ruther-
ford classiﬁcation, 2-5). Iliac artery revascularization without other adjunct
lower extremity intervention was performed in 60% of the limbs. High CRP
levels (>0.80 mg/dL) were present in 32 (27%) patients and high BNP
values (>100 pg/mL) in 24 (20%) patients. Kaplan-Meier analysis with
log-rank comparison demonstrated that elevated CRP levels associated
with clinical limb failure but only in limbs receiving interventions distal to
the external iliac artery (P < .01). High BNP levels did not affect limb
failure (0.91). Conversely, high BNP levels associated with a statistically
elevated MACE rate at 2 years of 36% vs 14% in patients with normal
BNP levels (P ¼ .01). Patients with high CRP trended toward having higher
rates of MACE (33% vs 14%) but failed to meet statistical signiﬁcance (P ¼
.053). Patients with high preintervention values of CRP and BNP were 10.6
times (95% conﬁdence interval, 2.6-42.6; P < .01) more likely to experience
MACE than patients with normal CRP and BNP values.
Conclusions: Preprocedure biochemical markers in endovascular
interventions for PAD can aide in predicting future limb related complica-
tions and late cardiovascular events. Potentially, improving biochemical
markers prior to intervention could improve outcomes.
The Impact of Personality Type on Objective Ambulatory Measures in
Patients with Intermittent Claudication
Daniel J. Torrent, Mandy R. Maness, Timothy W. Capps, Frank M. Parker,
Charles S. Powell, William M. Bogey, Jill N. Zink, Samuel F. Sears, Amanda
L. Whited, Michael C. Stoner. East Carolina University, Greenville, NC
Objectives: A type D (or distressed) personality is associated with
negative affectivity and social inhibition and is an independent predictor
of morbidity and mortality in patients with cardiac disease. There is little
data on this personality type in patients with intermittent claudication
(IC). The purpose of this study is to evaluate the difference in objective
measures of ambulation in patients with IC stratiﬁed by personality type.
Methods: Over a 1-year period, routine history, and physical, ankle
brachial index (ABI), and pulse volume recording were performed on IC
patients. Questionnaires assessing personality type, psychosocial factors
and perception of disease severity were recorded (Vascular Quality of Life,
Walking Impairment Questionnaire, Hospital Anxiety and Depression Scale,
Positive Health Expectations, and Type D Scale). A 6-minute walk test
(6MWT) was performed measuring distance to symptoms, total distance
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used to assess the correlation between ambulation and type D personality.
Results: Seventy-one patients were enrolled with a mean age of
62.5 6 1.14 years and mean ABI of 0.55 6 0.03. Mean distance to symp-
toms, and total distance walked were 83.76 80.1 m, and 206.56 126.3 m,
respectively. There were no signiﬁcant correlations between the type D
group and the questionnaires assessing psychosocial factors and perception
of disease severity. At 6MWT, 83.1% of the patients developed symptoms,
and 57.4% quit because of symptoms. Type D personality was present in
29.6% of the population (study, n ¼ 21). Compared with the nontype D
population (control, n ¼ 50), there were no differences in demographic
factors, comorbidities, or baseline ABI. Univariate analysis of objective
measures of ambulation (Table) demonstrate statistically signiﬁcant lower
distance to symptoms in the study group, and trends toward lower total
distance walked and quitting the 6MWT. A logistic regression model for
patients who quit the 6MWT found that the study group had increased
odds of quitting (OR 7.71; P ¼ 0.009) when controlling for confounders. A
multiple linear regression model for total distance walked showed that the
study group walked an average of 33.2 6 13.3 meters less than the control
group (P ¼ .016) when controlling for confounding variables.
Conclusions: Despite equivalent demographics, comorbidities, base-
line ABI, and perception of disease severity, the study group was limited
in ambulation distance and more likely to quit the 6MWT. These data
suggest that personality type is a strong predictor of disease impact in
patients with IC. Further study is needed regarding progression of disease
and response to treatment based on type D personality.
Table. Univariate analysis of objective ambulation outcomes
Study Control
VariableF(type D, n ¼ 21)ig 1.(n ¼ 50) PAge, years 60.9 6 2.0 63.1 6 1.4 .36
ABI 0.55 6 0.26 0.55 6 0.19 .93
6MWT quit 70.0% 52.1% .17
6MWT developed symptoms 76.2% 86.0% .33
6MWT distance to symptoms, m 57.4 6 12.3 93.4 6 13.3 .05
6MWT total distance, m 170.3 6 25.0 221.6 6 18.8 .11Optimizing Treatment for Chronic Mesenteric Ischemia: A
Comparison of Open and Endovascular Repair in a Clinical Decision
Model
Wouter Hogendoorn1, M. G. Myriam Hunink2, Felix JV. Schlosser1, Frans
L. Moll3, Bart E. Muhs1, Bauer E. Sumpio1. 1Yale University, New Haven,
Conn; 2Erasmus MC, Rotterdam, The Netherlands; 3University Medical
Center Utrecht, Utrecht, The Netherlands
Objectives: Chronic mesenteric ischemia (CMI) is an uncommon
disease caused by stenosis or occlusion of one or more visceral arteries.
Open repair (OR) has been the treatment of choice for many years, but
endovascular repair (EV) has been increasingly utilized with good short-
term results. Unfortunately, there is no level-1-evidence that compares these
two major treatment modalities for the treatment of CMI, and there are no
clear guidelines on management strategies. In this study, we utilized a deci-
sion analysis model to evaluate the different interventions.Methods: A Markov-state transition model was developed using
TreeAge Pro 2012 (TreeAge Inc, Williamstown, Mass) to simulate a hypo-
thetical cohort of 10,000 65-year-old female patients with CMI requiring
treatment with either OR or EV. Data and probabilities to populate the
decision model, including perioperative mortality risks, complication-, rein-
tervention-, and patency rates and disease-speciﬁc mortality, were retrieved
from original and systematic reviews for CMI. Costs were retrieved using
the 2013 Medicare database. Outcomes evaluated were quality-adjusted
life years (QALYs), total expected lifetime costs and an incremental cost-
effectiveness ratio (ICER) evaluated from the healthcare perspective. Exten-
sive sensitivity analyses were performed for different clinical scenarios and
probabilistic sensitivity analysis was performed to assess robustness of the
model.
Results: For 65-year-old female patients with CMI and an average
risk for operation, EV is slightly preferred with 10.24 expected QALYs
(95% conﬁdence interval [CI], 9.98-10.40) vs 9.93 QALYs (95% CI,
9.64-10.19) for OR. The difference between the two strategies is compa-
rable to 4 months in perfect health (0.31 QALYs; 95% CI, 0.06-0.56).
Sensitivity analysis shows that the younger the patient, the greater the differ-
ence in effectiveness in favor of EV: 0.4 QALYs (at 50 years) to 0.1 QALYs
(at 95 years). Total expected reinterventions/patient are 1.56 for EV vs
0.28/patient in the OR group. At every age group, the number of expected
reinterventions is around ﬁve times higher for patients initially treated with
EV. Total expected costs for the reference-case patient are $48,440 6
$8,665 for OR and $43,099 6 $5,998 for EV. For patients between 50
years and 55 years old, EV is more expensive compared with OR but the
incremental cost-effectiveness ratio for EV is under the willingness-to-pay
threshold of $60,000/QALY. After the age of 55, costs for OR are higher
and effectiveness is lower, and therefore OR is dominated by EV.
Conclusions: The results of this decision analysis suggest that EV is
slightly favored for patients with CMI. Effectiveness of EV compared with
OR is always higher for every age group and risk proﬁle. Although EV
has up to ﬁve times more expected reinterventions, EV appears to be
cost-effective for all patient groups. Decision analysis provides a useful
means to monitor outcomes and cost-effectiveness of different treatment
options.
Carotid Artery Stenting Has Increased Risk of External Carotid Artery
Occlusion Compared with Carotid Endarterectomy
Kevin A. Brown1, Dina S. Itum2, James G. Reeves2, Yazan Duwayri2, Ravi
Rajani2, Ravi K. Veeraswamy2, Shipra Arya1, Atef Salam1, Thomas F.
Dodson2, Luke P. Brewster1. 1Emory University/Atlanta VA Medical
Center, Atlanta, Ga; 2Emory University, Atlanta, Ga
Objectives: Carotid artery stenting (CAS) can offer advantages over
carotid endarterectomy (CEA) in certain patient populations, such as those
with hostile necks. However, CEA and CAS are fundamentally different.
CAS routinely covers the external carotid artery (ECA), and we hypothesize
that this increases the risk of ECA occlusion. Since the ECA can be an
important source of cerebral blood ﬂow in cases of high-grade internal
carotid artery stenosis or occlusion, ECA occlusion may be important to
long-term cerebral perfusion. Furthermore, CAS causes disturbed ﬂow
into the ECA that likely promotes ECA stenosis and may contribute to
in-stent restenosis (ISR). Our objective was to identify whether CAS
increased the rate of external carotid artery occlusion, and whether ECA
occlusion was associated with in-stent restenosis.
Methods: Patients undergoing CAS or CEA from February 200 to
February 2012 with follow-up carotid ultrasounds in our system were
